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Super-enhancers are tissue-specific cis-regulatory
elements that drive expression of genes associated
with cell identity and malignancy. A cardinal feature
of super-enhancers is that they are transcribed to
produce enhancer-derived RNAs (eRNAs). It remains
unclear whether super-enhancers robustly activate
genes in situ and whether their functions are attribut-
able to eRNAs or the DNA element. CRISPR/Cas9
was used to systematically delete three discrete
super-enhancers at the Nanog locus in embryonic
stem cells, revealing functional differences in Nanog
transcriptional regulation. One distal super-enhancer
45 kb upstream of Nanog (45 enhancer) regulates
both nearest neighbor genes, Nanog and Dppa3.
Interestingly, eRNAs produced at the 45 enhancer
specifically regulate Dppa3 expression by stabilizing
looping of the 45 enhancer and Dppa3. Our work
illustrates that genomic editing is required to deter-
mine enhancer function and points to a method to
selectively target a subset of super-enhancer-regu-
lated genes by depleting eRNAs.
INTRODUCTION
Embryonic stem cells (ESCs) are distinguished by two unique
properties: the ability to undergo unlimited self-renewal while
maintaining pluripotency and the capacity to differentiate into all
embryonic germ layers. Transcription factors (TFs) form the core
machinery that maintain pluripotency by binding ESC specific
cis-regulatory elements (CREs) that regulate transcription inde-
pendentofdistanceandorientation (Chenetal., 2008).While there
have been great advances in identifying the genomic location of
ESC-specific enhancers based on epigenetic signatures, much
remains unknown about their exact mechanism and contribution
tocell identity.MurineESCsarean idealmodel to studyepigenetic
regulation of cell identity, as the TF and chromatin interaction
networks (e.g., chromatin immunoprecipitation sequencing
[ChIP-seq] and high-throughput chromosome conformation cap-
ture [Hi-C]) controlling pluripotency have beenwell characterized,
resulting in identification of highly active cell-type-specific CREs,Cel
This is an open access article under the CC BY-Ntermed super-enhancers or stretch enhancers, which associate
with genes critical to cell identity (Whyte et al., 2013). In addition,
super-enhancers play a critical role in driving disease processes
such as cancer, and targeting themwith small molecule inhibitors
is an active area of research (Love´n et al., 2013). Murine ESCs
have 231 super-enhancers, which are large (10 kb) CREs occu-
pied by an extremely high density of the pluripotency-critical TFs
Nanog, Oct4, and Sox2 (NOS) and coactivators such asMediator
(Whyte et al., 2013). Further, super-enhancers are defined by very
high levelsof theactiveenhancerepigeneticmarkhistone3Lysine
27 Acetylation (H3K27Ac), are bound by the initiating form of RNA
polymerase II (serine 5 phosphorylated [Ser5P] RNAPII), and are
bidirectionally transcribed to produce unspliced long non-coding
RNAs (lncRNAs) termed enhancer RNAs (eRNAs; Pulakanti et al.,
2013; Hnisz et al., 2013). eRNAs are a mark of highly active
enhancers (Ørom et al., 2010; Kim et al., 2010; De Santa et al.,
2010; Pulakanti et al., 2013) and have diverse roles in regulating
transcription, including stabilizing enhancer-promoter looping
by tethering cohesin and Mediator complexes at interacting
CREs (Li et al., 2013; Lai et al., 2013; Hsieh et al., 2014; Feng
et al., 2006; Figure S1A). How discrete super-enhancers in close
proximity work together to regulate genes and the relative contri-
bution of the DNA element and its transcribed product (eRNA) to
gene expression are currently unknown.
The 160-kb extended Nanog locus on murine chromosome 6
contains four genes (Apobec1, Gdf3, Dppa3, and Nanog) that
have critical roles early in embryonic development and are
NOS regulated in ESCs. Nanog is a homeobox transcription fac-
tor and is required for pluripotency and self-renewal in ESCs
(Chambers et al., 2003; Mitsui et al., 2003). Enhancer-promoter
interactions at the extended Nanog locus have been studied,
revealing a complex network of putative CREs that interact
and may co-regulate genes (Levasseur et al., 2008; Apostolou
et al., 2013; de Wit et al., 2013). Interestingly, the Nanog locus
contains three super-enhancers, but the relative contribution
of each CRE to Nanog expression has not been studied
in situ. We have previously demonstrated one distal super-
enhancer 45 kb upstream of Nanog is transcribed and produces
ESC-specific eRNAs (Pulakanti et al., 2013). Thus, the extended
Nanog locus is an ideal genomic region to study the function
of multiple super-enhancers and the regulatory capacity of the
eRNAs they produce.
Here, we demonstrate striking differences in super-enhancer
transcriptional regulation of Nanog. In addition, we show that al Reports 17, 19–28, September 27, 2016 ª 2016 The Author(s). 19
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Nanog Neighbors Three Putative Super-Enhancers
(A) Integrated Genome Viewer (IGV) image of genome-wide chromatin immunoprecipitation (ChIP-seq) datasets in wild-type (WT) ESCs at the extended Nanog
locus. Super-enhancers are indicated below in red.
(B) Luciferase reporter plasmids containing the Nanog promoter and a fragment of the 45, 5, or +60 enhancer in both orientations were transfected into WT
ESCs or a fibroblast cell line (NIH/3T3). All samples had a fold change (y axis) and statistical analysis calculated relative to a plasmid containing Nanog promoter
only, which was set to one (dashed line). n = 3. Error bars indicate the SEM between experimental replicates. *p < 0.05, **p < 0.01 using a one-sample Student’s
t test.distal super-enhancer differentially regulates multiple neigh-
boring genes and that eRNAs produced at this super-enhancer
selectively activate expression of one neighboring gene. Thus,
eRNAs are critical to enhancer function. This study provides
insight into the mechanism of transcribed enhancers in a cluster
of co-regulated genes, specifically parsing out genes that cluster
withahighly active transcribedenhancer versusa subset of genes
the enhancer regulates.
RESULTS
Super-Enhancers Cluster with Nanog
Whyte et al., (2013) identified 231 tissue-specific super-en-
hancers in murine ESCs, which represent <5% of all enhancers.
Subsequent studies have examined chromatin regions that
interact with these highly active elements by genome-wide
chromosome conformation capture (3C) approaches such as
Hi-C or circular chromosome conformation capture (4C), sug-20 Cell Reports 17, 19–28, September 27, 2016gesting a functional role of long-range chromatin interactions
in the maintenance of pluripotency (Schoenfelder et al., 2015;
Apostolou et al., 2013; de Wit et al., 2013). Nanog is unique
from other pluripotent loci, as it lies within 100 kb of three su-
per-enhancers: 45 kb upstream (45 enhancer), 17-kb region
immediately upstream, and 60 kb downstream (+60 enhancer)
of Nanog (Figure 1A). In this paper, we focus on a RNAPII-occu-
pied enhancer 5 kb upstream of Nanog (5 enhancer) as it is
the most active element within the large proximal super-
enhancer region (Figure 1A). Luciferase reporter assays show
that all three super-enhancers increase transcriptional activity
from the Nanog promoter in both orientations in ESCs but not
in fibroblasts, indicating tissue-specific enhancer activity of
the Nanog promoter (Pulakanti et al., 2013; Das et al., 2011;
Figure 1B).
A common feature of all enhancers is that they interactwithpro-
moters by looping out the intervening chromatin segment (Guo
et al., 2011; Nora et al., 2012; Sanyal et al., 2012; Rao et al.,
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Figure 2. A Looping Event Is Detected between Nanog and Three Super-Enhancers by Chromosome Conformation Capture
(A–C) The x axis indicates genomic distance (kilobases) from the Nanog promoter (anchor), and the y axis indicates the normalized interaction ratio. The peak
interaction was normalized to one for eachWT ESC experimental replicate. IGV images showing HaeIII cut sites, 3C primers, and ChIP-seq binding profiles inWT
ESCs are shown below each graph. The anchor primer is not shown in (C). Error bars indicate the SEM between experimental replicates. *p < 0.05 and #p < 0.05,
## p < 0.01 using a one-sample and two-sample Student’s t test, respectively.2014; Figure S1A). To detect interaction of each super-enhancer
with Nanog, we used 3C. Previous work has shown that the 5
and 45 enhancers interact with Nanog (Levasseur et al., 2008;
Apostolou et al., 2013), which we confirmed (Figures 2A and
2B). In addition, we identified an unappreciated interaction be-
tween the +60 enhancer and Nanog in ESCs (Figure 2C). Interac-
tions were increased above a control fibroblast cell line where
Nanog is not expressed. Further, published Hi-C data show clus-
tering of numerous CREs at the extended Nanog locus, similar
to our 3C data (Figure S1B). To verify locus-wide clustering ofother CREs at this locus in ESCs, we demonstrate an interaction
between Dppa3 and the +60 enhancer (Figure S1C) and an
enhancer-enhancer interaction between the 45 and 5 en-
hancers (Figure S1D). In sum, we confirm locus-wide clustering
of co-regulated (NOS-occupied) CREs with Nanog that function
as putative enhancers in reporter assays.
Functional Differences of Nanog Super-Enhancers
Super-enhancers have beenproposed to control genes critical to
cell identity such as Nanog. Given that all three super-enhancersCell Reports 17, 19–28, September 27, 2016 21
are putative Nanog enhancers, we asked whether each CRE
is required for robust Nanog expression. To determine in situ
enhancer function, we systematically deleted each CRE using
CRISPR/Cas9 genomic editing (Figure 3A). To delete the 5
and +60 enhancer, we designed sequence-specific guide
RNAs (gRNAs) flanking each enhancer (Figures S2A and S2B).
We obtained multiple independent clones containing large
biallelic deletions (10.5 kb) of the +60 enhancer. Using the
same approach, we efficiently recovered clones containing
only monoallelic deletions (2.5 kb) of the proximal 5 enhancer
(Figure S2C). Finally, using an alternative CRISPR-mediated
homology-directed repair (HDR) approach, we obtained several
clones containing biallelic deletions (2.85 kb) of the45enhancer
(FigureS2D). All super-enhancer-deleted clones recovered retain
colonymorphology and stain positive for alkaline phosphatase, a
surface marker of pluripotency (Figure S2E).
Surprisingly, knockout of individual super-enhancers resulted
in different effects on gene expression at the extended Nanog
locus. Specifically, biallelic deletion of the 45 enhancer results
in decreased expression of both nearest neighbor genes Nanog
and Dppa3, while biallelic deletion of the +60 enhancer results
in minimal changes in expression of any gene at the Nanog
locus (Figures 3B and 3C). Presence of a neomycin resistance
(Neo) cassette in place of the 45 enhancer had modest
effects on Dppa3 expression but did not alter Nanog expres-
sion. Differences in expression of Apobec1 and Oct4 between
45-enhancer-deleted clones with and without Neo is likely
clone-to-clone variation (Figure S3C). Interestingly, monoallelic
5-enhancer-deleted ESCs show an 50% decrease in Nanog
expression. This suggests that the 5 enhancer is required for
robust Nanog expression and biallelic deleted clones were not
recovered likely due to intolerance for enhancer loss secondary
to loss of Nanog expression, in line with work demonstrating
Nanog+/, but not Nanog/, mice are viable (Mitsui et al.,
2003). No significant change in expression was observed
at other nearby NOS-regulated genes (Gdf3 and Apobec1)
following deletion of any enhancer (Figure 3B). While 5- and
45-enhancer-deleted clones showed a 40%–50% decrease
in Nanog expression, ESCs retain wild-type (WT) expression
of other pluripotency-associated TFs, indicating the pluripo-
tency network is intact (Figure S3A). Accordingly, there was
no biologically significant increase (10- to 100-fold) in a range
of lineage-specific markers as we have observed previously
when ESCs lose pluripotency and differentiate (Stelloh et al.,
2016; Figure S3B). These findings are in contrast to genome
editing studies at the Sox2 locus where biallelic deletion of
a distal super-enhancer in ESCs resulted in an 80%–90%
decrease in Sox2 expression and elevated expression of
germ layer lineage markers (Zhou et al., 2014; Li et al., 2014).
Taken together, despite identical epigenetic signatures, re-
porter activity, and chromatin interaction, genomic editing
reveals important functional variation of super-enhancers in
Nanog regulation, where only the most proximal CRE (5
enhancer) appears critical to Nanog expression. These results
provide insights into the complexity of enhancer function during
development and demonstrate that isolated super-enhancers
have differential function on cell-critical gene expression that
can only be uncovered by deleting the CREs (Figure 3C). More-22 Cell Reports 17, 19–28, September 27, 2016over, this parallels work showing differential function of constit-
uent enhancers within one large super-enhancer (Huang et al.,
2016).
The 45 Enhancer Regulates Nanog and Dppa3
Surprisingly, deletion of the 45 enhancer resulted in an 60%
decrease in Dppa3 expression (Figure 3B). Dppa3 lies 35 kb
upstream of the 45 enhancer and has roles in DNA imprinting
in very early embryogenesis but is dispensable for pluripotency
(Nakamura et al., 2007; Figures 1A and 3B). To confirm that
reduction in Dppa3 expression is not a result of decreased
Nanog (or vice versa), we depleted either Dppa3 or Nanog
mRNA by RNAi. Nanog depletion resulted in a >10-fold increase
in Dppa3 expression, consistent with a previous report that
Nanog represses Dppa3 (Sharov et al., 2008; Figure S4A).
Dppa3 depletion led to minimal changes in Nanog expression
and other pluripotency genes such asSall4 (Figure S4B), demon-
strating that Dppa3 does not regulate pluripotency. We identified
an interaction of the 45 enhancer with the Dppa3 promoter in
ESCs using 3C, which was not present in fibroblasts (Figure 4A).
Finally, we show that the 45 enhancer activates Dppa3 in
reporter assays in ESCs, but not in fibroblasts (Figure 4B).
Thus, we determined that the 45 enhancer regulates both
nearest neighbor genes within a highly active region of co-regu-
lated genes in ESCs. Further, the modest increase in Dppa3
expression in 5 enhancer monoallelic ESCs demonstrates
that the 5 enhancer regulates Nanog, but not Dppa3 (Figures
3B and 3C). Interestingly, despite studies showing clustering
of Apobec1 and Gdf3 with Nanog (Levasseur et al., 2008;
Apostolou et al., 2013), our genome editing results reveal that
none of the super-enhancers regulate these genes (Figure 3B).
This suggests linear DNA proximity of the super-enhancer is
of functional importance within this compact cluster of co-regu-
lated CREs.
eRNAs Produced at the 45 Enhancer Specifically
Regulate Dppa3
In just a few years since their discovery, eRNAs have been
shown to have diverse functions in transcriptional regulation,
including roles in enhancer-promoter looping (Lai et al., 2013;
Li et al., 2013; Hsieh et al., 2014). We previously identified
ESC-specific eRNAs produced at the 45 enhancer (Pulakanti
et al., 2013). The 45 enhancer serves as an interesting
opportunity to study eRNA function, as this CRE regulates
two neighboring genes, Nanog and Dppa3. To identify
activating properties of 45 eRNAs at these two genes, we tar-
geted eRNAs for depletion with modified antisense
oligonucleotides (ASOs). eRNAs are restricted to the nucleus,
and therefore ASOs, which act by a nuclear-specific RNase
H mechanism, have been used to efficiently deplete them.
ASOs were designed to target peak levels of eRNAs as
determined by global run-on sequencing (GRO-seq; Kaikkonen
et al., 2013; Li et al., 2013; Figure S2D), which detects nascent
RNA transcription and thus is a sensitive technique to detect
eRNAs. Our level of eRNA depletion is comparable to other
studies, as ASOs reproducibly depleted eRNAs by >60% rela-
tive to a non-targeting ASO (Kaikkonen et al., 2013; Li et al.,
2013; Figure 5A). Maintaining >50% depletion is challenging,
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Figure 3. Genomic Editing Reveals Functional Differences in Super-Enhancer Regulation of Nanog
(A) Schematic of CRISPR-mediated super-enhancer deletion at the Nanog locus.
(B) Expression of genes within the extended Nanog locus in WT ESCs. Two representative clones are shown for 45- (Neo present), 5-, and +60-enhancer-
deleted clones. Error bars indicate the SEM between experimental replicates. n = 3. All samples had a fold change (y axis) and statistical analysis (one-sample
Student’s t test) calculated relative toWT ESCs that were set to one (dashed line). A two-sample Student’s t test was used to compare clones. *p < 0.05, **p < 0.01
and ## p < 0.01 using a one-sample and two-sample Student’s t test, respectively.
(C) Chart depicting changes in gene expression of Nanog and Dppa3 following deletion of each enhancer.
Cell Reports 17, 19–28, September 27, 2016 23
010
20
30
40
50
60
-45 Plus Enhancer -45 Minus Enhancer
Fo
ld
C
ha
ng
e
R
el
at
iv
e
to
D
pp
a3
Pr
om
ot
er
O
nl
y WT ESCs
Fibroblasts
B
A
Dppa3 Promoter Luciferase Enhancer
*
*
0
0.2
0.4
0.6
0.8
1
1.2
0 10 20 30 40 50
N
or
m
al
iz
ed
In
te
ra
ct
io
n
R
at
i o
Distance (kb) From Dppa3 Promoter
WT ESCs
Fibroblasts
*
#
Primers
HaeIII
H3K27Ac
Smc1a
Nanog
Dppa3 -45 Enhancer
(0-195)
(0-20)
(0-17)
#
#
Figure 4. The 45 Enhancer Regulates Dppa3
(A) A looping event is detected between the45 enhancer andDppa3 by 3C in
WT ESCs. The x axis indicates genomic distance (kilobases) from the Dppa3
promoter (anchor), and the y axis indicates the normalized interaction ratio.
The peak interaction was normalized to one for each WT ESC experimental
replicate. The IGV image showing HaeIII cut sites, 3C primers, and ChIP-seq
binding profiles in WT ESCs is shown below the graph.
(B) A luciferase reporter plasmid containing the Dppa3 promoter and a frag-
ment of the 45 enhancer in both orientations was transfected into WT ESCs
or a fibroblast cell line (NIH/3T3). All samples had a fold change (y axis) and
statistical analysis calculated relative to a plasmid containing Dppa3 promoter
only, which was set to one (dashed line). n = 3.
Error bars indicate the SEM between experimental replicates. *p < 0.05 and
# p < 0.05 using a one-sample and two-sample Student’s t test, respectively.
24 Cell Reports 17, 19–28, September 27, 2016as eRNAs are a short-lived molecule and restricted to focal
region(s) of the nucleus. Interestingly, 24-hr depletion of eRNAs
at the 45 enhancer showed a >40% decrease in Dppa3
expression, with no change in Nanog expression (Figure 5A).
This is in contrast to changes following 45 enhancer deletion,
which result in decreased expression of both genes (Fig-
ure 3B). This demonstrates specificity of eRNAs to regulate
only one of the nearest neighbor genes and that eRNAs are
partially required for the cis-activating properties of this su-
per-enhancer.
Previous studies have shown that lncRNAs interact with
epigenetic regulators involved in DNA methylation (Berghoff
et al., 2013), catalyzation of enhancer histone marks H3K27Ac
(Wang et al., 2008), and histone 3 Lysine 4 methylation
(H3K4me; Yang et al., 2014). To examine the mechanism by
which eRNAs regulate Dppa3, we first tested for changes in
active epigenetics marks of the enhancer. Following eRNA
depletion, we observed no change in H3K4me1 or H3K27Ac
levels at the 45 enhancer and a putative transcribed enhancer
upstream ofOct4 (control genomic region on a different chromo-
some) by chromatin immunoprecipitation (Figures S5A and
S5B). Highly active enhancers also exhibit DNA hypomethylation
compared to typical enhancers. Following eRNA depletion, we
observed no change in DNA methylation at two CpG clusters
within the 45 enhancer (Pulakanti et al., 2013; Figure S5C). In
sum, transient depletion of eRNAs does not result in alteration
of epigenetics marks of an active enhancer, implying eRNAs
are not required for their maintenance.
Recent work highlights a role of eRNAs in stabilizing enhancer-
promoter looping through interactions with the cohesin and
Mediator complexes (Li et al., 2013; Lai et al., 2013). Cohesin
is enriched at super-enhancers, which are RNAPII bound and
transcribed (Hnisz et al., 2013). Using published enhancer data-
sets, we show that Smc1a (a component of the cohesin complex)
is enriched at all ESC-transcribed enhancers relative to eRNA-
negative enhancers (Pulakanti et al., 2013; Figure S5D). This sug-
gests that eRNAs may have a generalized role to tether looping
factors such as cohesin to stabilize chromatin interactions
in ESCs. To determine the mechanism underlying altered
Dppa3 expression, we tested whether eRNA depletion disrupts
enhancer-promoter looping by 3C. Using eRNA ASO 1, which
results in the most efficient depletion of eRNAs, we observed a
50% decrease in looping of the 45 enhancer at the Dppa3
promoter (Figure 5B). There was no change in interaction of
the 45 enhancer with Nanog or the 5 enhancer (Figure 5B).
Other interactions at the Nanog locus were also unchanged
following eRNA depletion (Figure S5E). Thus, 45 eRNAs stabi-
lize specific enhancer-promoter interactions within a cluster
of pluripotency-associated genes to drive robust Dppa3
expression. Our results are in agreement with studies showing
no change in active enhancer marks following disruption of
enhancer-promoter looping by depleting cohesin (Seitan et al.,
2013). Finally, we confirmed that deletion of the 45 enhancer
does not alter other super-enhancer interactions with Nanog
(Figure 5C), further substantiating that 45 eRNAs specifically
regulate a single gene within the cluster of CREs and that the
5 enhancer is sufficient to maintain pluripotency (Figures 3B
and 5C).
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Figure 5. 45 eRNAs Regulate Dppa3 Expression by Stabilizing Enhancer-Promoter Interactions
(A) 24-hr depletion of 45 eRNAs using antisense oligonucleotides (ASOs) results in a reduction in Dppa3 expression. All samples had a fold change (y axis) and
statistical analysis calculated relative to a non-targeting ASO, which was set to one (dashed line). n = 4.
(B) Chromatin interactions (3C) between the 45 enhancer and neighboring cis-regulatory elements following eRNA depletion using eRNA ASO 1. Statistical
analysis was calculated relative to the non-targeting ASO, which was set to one (dashed line). n = 3.
(C) Chromatin interactions (3C) between Nanog and the 5 and +60 enhancers in a 45-enhancer-deleted ESC line (Neo removed). Statistical analysis was
calculated relative to WT ESCs, which was set to one (dashed line). n = 3.
For (A)–(C) error bars indicate SEM between experimental replicates. *p < 0.05, **p < 0.01 using a one-sample Student’s t test.
(D) Two-dimensional schematic of the extended Nanog locus before and after 45 eRNA depletion. 45 eRNAs maintain interaction of Dppa3 and the 45
enhancer and high levels of Dppa3 expression.DISCUSSION
In summary, our data demonstrate that in situ genomic editing
is required to unravel the functional role of enhancers, particu-
larly when numerous co-regulated CREs cluster within a com-
pacted chromatin space. Expression changes following CREablation suggests there is a super-enhancer functional hierar-
chy at the Nanog locus, where the 5 enhancer is the only
CRE required for robust Nanog expression and pluripotency.
Further, by combining genome editing with eRNA depletion,
we demonstrate that eRNAs have a functional role by
specifically regulating one of the enhancer associated genesCell Reports 17, 19–28, September 27, 2016 25
(Figure 5D). This is in contrast to recent work by Paralkar et al.,
(2016), where depletion of an enhancer-transcribed long inter-
genic non-coding RNA (Lockd), which belongs to a class
of lncRNAs distinct from eRNAs and is capable of acting in
trans, did not phenocopy gene expression changes following
enhancer deletion. Rather, our work supports a model whereby
eRNAs have critical roles in organizing three-dimensional nu-
clear interactions, thereby activating a select subset of interact-
ing genes regulated by a super-enhancer (Li et al., 2013; Lai
et al., 2013; Hsieh et al., 2014).
Under commonly used in vitro serum and leukemia inhibitory
factor (LIF) culture conditions, Nanog and Dppa3 are two of the
most heterogeneously expressed genes on a cell-to-cell basis
(Galonska et al., 2015). ESCs maintained in serum-free defined
conditions containing two kinase inhibitors to suppress differ-
entiation cues (2i; Mek and Gsk3 inhibitors) have higher and
more homogenous levels of Nanog as well as Dppa3 (Silva
et al., 2009; Galonska et al., 2015). These ESCs are in an
epigenetically and transcriptionally distinct ‘‘naive’’ pluripotent
state, likely as a result of dynamic NOS binding at enhancer
elements (Galonska et al., 2015). Interestingly, gene expres-
sion differences in Nanog and Dppa3 in these two in vitro
conditions parallel expression changes observed in WT and
45-enhancer-deleted ESCs. This suggests that dynamic
epigenetic changes in the 45 enhancer landscape in the
two ESC states result in differential regulation of Nanog and
Dppa3.
In addition to driving expression of lineage-critical factors
during development, super-enhancers play a critical role in
pathologic processes, including malignancies (Hnisz et al.,
2013). Inhibition of transcriptional co-activators and chromatin
regulators that densely occupy super-enhancers has been
shown to decrease aberrant expression of oncogenes in tumor
cells, including Myc (Love´n et al., 2013). However, current
approaches using small molecules to target co-activators
such as Brd4 lack specificity and disrupt most genes regulated
by super-enhancers. Our work points to a method to selectively
target a subset of genes regulated by super-enhancers in
pathologic states. ASOs, which are used as RNA-targeting
therapies for a variety of diseases (Arun et al., 2016), offer an
intriguing alternative to small molecules, as they allow direct
pharmacological targeting of activating eRNAs at oncogenic
loci.
EXPERIMENTAL PROCEDURES
Cell Culture, RNA Isolation, and Real-Time qRT-PCR
ESCs were cultured under previously described conditions (Rao et al., 2010).
Total RNA isolation, cDNA conversion, and qPCRwas performed as previously
described (Pulakanti et al., 2013; Stelloh et al., 2016). Primers used for
qRT-PCR, ChIP-qPCR, and 3C are listed in Table S1 (all primers in this study
were designed using mm9).
Reporter Plasmid Generation
Luciferase reporter plasmids were generated and analyzed similar to Pulakanti
et al. (2013). Each enhancer was cloned into the SalI site (in both orientations)
and each promoter into the KpnI/XhoI site of the Firefly luciferase plasmid
(pGL2, Promega). Reporter constructs were transiently transfected into cells
using Lipofectamine 2000 (Invitrogen) along with a control plasmid (Renilla
luciferase, pRL-EF) for 30 hours.26 Cell Reports 17, 19–28, September 27, 2016Chromosome Conformation Capture
3C libraries for ESC and NIH/3T3 crosslinked chromatin were generated as
described in Stelloh et al., (2016) using a modified protocol from Hage`ge
et al., (2007). Interaction between the anchoring point and distal fragments
was determined by SYBR Green qPCR and normalized to bacterial artificial
chromosome/clone (BAC) templates. Fold changes were divided by relative
interaction at the Ercc3 locus (a housekeeping gene known to loop in all cell
types) to account for differences in library generation (Table S1). At least two
independent libraries were used for each cell line, and statistical analysis
was calculated relative to WT ESCs. For each genomic region tested, the
peak normalized interaction for each ESC library was set to one.
Genome Editing
To generate 45 Nanog super-enhancer-deleted ESC clones, a single gRNA
designed using the CRISPR design tool (http://crispr.mit.edu/) was cloned
into the Cas9-expressing vector px459 (Cong et al., 2013). An HDR vector
(pL452) containing a floxed Neo cassette flanked by homology regions was
co-transfected along with the gRNA in WT ESCs. Individual clones that were
resistant to both puromycin and G418 were isolated and expanded for geno-
typing (Table S1). To generate 5 and +60 Nanog super-enhancer-deleted
ESC clones, we used two gRNAs (designed same as above) as described in
Zhou et al., (2014) and Huang et al., (2016) (Table S1).
Antisense Oligonucleotides
ASOs targeting eRNAs produced at the 45 Nanog super-enhancer were de-
signed by Integrated DNA Technologies (Table S1). ASOs were designed with
phosphorothioate bonds and a 10-bp gapmer flanked by 5-bp blocks of 20-O-
methyl modified ribonucleotides that protect the ASO from nuclease degrada-
tion. ASOs were transiently transfected at 100 nM with Lipofectamine 2000.
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